|29th January 2021||Anirvan Ghosh||250,000||Grant/award etc.||$0.00|
|16th December 2020||Nathaniel E David||1,700,000||Open or private sale||$5.24||$8,908,000.00|
|13th September 2020||Anirvan Ghosh||300,000||Grant/award etc.||$0.00|
|13th September 2020||Lynne Marie Sullivan||240,000||Grant/award etc.||$0.00|
|13th September 2020||Jamie Dananberg||240,000||Grant/award etc.||$0.00|
|13th September 2020||Alexander Azoy||135,000||Grant/award etc.||$0.00|
|9th September 2020||Ii Robert C. Goeltz||5,000||Open or private purchase||$21.57||$107,848.50|
|22nd June 2020||Ii Robert C. Goeltz||2,483||Payment by withholding||$9.67||$24,010.61|
|22nd June 2020||Jamie Dananberg||2,483||Payment by withholding||$9.67||$24,010.61|
|22nd June 2020||Nathaniel E David||2,483||Payment by withholding||$9.67||$24,010.61|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Unity Biotechnology, Inc. operates as a biotechnology company. The company was founded by Nathaniel David, Jan van Deursen, Judith Campisi and Daohong Zhou in March 2009 and is headquartered in Brisbane, CA.